Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Determinants of treatment outcomes of multidrug-resistant tuberculosis: an Individual Patient Data Meta-Analysis

FY 2016-17

Summary
Multidrug-resistant tuberculosis (MDR-TB) has become a major threat to global tuberculosis control in recent years. MDR-TB infection is associated with lengthy treatment duration, use of toxic drugs, and generally poor outcomes. In the past six years, newer drugs and regimens have been used to treat MDR-TB, but there is very little good evidence to guide current MDR-TB therapy.Between August and November 2015, I worked on a systematic review that identified 74 studies, published since 2009, that reported MDR-TB treatment regimens and outcomes. Since January 2016, I have been working on an individual patient data (IPD) meta-analysis to determine optimal treatment for MDR-TB. As a first step, I invited authors of the 74 studies to participate in this IPD study. A total of 50 TB research groups agreed to share their data. I am now assembling all datasets into one database, with detailed clinical and treatment information for 12,245 MDR-TB patients.For my MSc thesis, I will analyze this data using appropriate meta-analytical methods. Objectives of the analysis include identifying determinants of treatment outcomes: efficacy of specific drugs, such as later-generation fluoroquinolones, linezolid and bedaquiline; adverse events associated with individual drugs; and the optimal number of drugs and duration of MDR-TB therapy.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367177
Name
Lan Zhiyi
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determinants of treatment outcomes of multidrug-resistant tuberculosis: an Individual Patient Data Meta-Analysis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Event; Drug Efficacy; Drug Resistance; Drug Safety; Individual Patient Data Meta-Analysis; Systematic Review; Treatment Regimen; Tuberculosis
Abstract
Multidrug-resistant tuberculosis (MDR-TB) has become a major threat to global tuberculosis control in recent years. MDR-TB infection is associated with lengthy treatment duration, use of toxic drugs, and generally poor outcomes. In the past six years, newer drugs and regimens have been used to treat MDR-TB, but there is very little good evidence to guide current MDR-TB therapy.Between August and November 2015, I worked on a systematic review that identified 74 studies, published since 2009, that reported MDR-TB treatment regimens and outcomes. Since January 2016, I have been working on an individual patient data (IPD) meta-analysis to determine optimal treatment for MDR-TB. As a first step, I invited authors of the 74 studies to participate in this IPD study. A total of 50 TB research groups agreed to share their data. I am now assembling all datasets into one database, with detailed clinical and treatment information for 12,245 MDR-TB patients.For my MSc thesis, I will analyze this data using appropriate meta-analytical methods. Objectives of the analysis include identifying determinants of treatment outcomes: efficacy of specific drugs, such as later-generation fluoroquinolones, linezolid and bedaquiline; adverse events associated with individual drugs; and the optimal number of drugs and duration of MDR-TB therapy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lan, Zhiyi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~